Menu
GeneBe

rs113645050

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_015141.4(GPD1L):c.465C>T(p.Ala155=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000901 in 1,614,138 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00087 ( 8 hom. )

Consequence

GPD1L
NM_015141.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.11
Variant links:
Genes affected
GPD1L (HGNC:28956): (glycerol-3-phosphate dehydrogenase 1 like) The protein encoded by this gene catalyzes the conversion of sn-glycerol 3-phosphate to glycerone phosphate. The encoded protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). Defects in this gene are a cause of Brugada syndrome type 2 (BRS2) as well as sudden infant death syndrome (SIDS). [provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant 3-32140326-C-T is Benign according to our data. Variant chr3-32140326-C-T is described in ClinVar as [Benign]. Clinvar id is 263656.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-32140326-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.11 with no splicing effect.
BS2
High AC in GnomAd at 179 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GPD1LNM_015141.4 linkuse as main transcriptc.465C>T p.Ala155= synonymous_variant 4/8 ENST00000282541.10
GPD1LXM_006713068.3 linkuse as main transcriptc.324C>T p.Ala108= synonymous_variant 3/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GPD1LENST00000282541.10 linkuse as main transcriptc.465C>T p.Ala155= synonymous_variant 4/81 NM_015141.4 P1

Frequencies

GnomAD3 genomes
AF:
0.00118
AC:
179
AN:
152164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0133
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00167
AC:
419
AN:
251326
Hom.:
2
AF XY:
0.00164
AC XY:
223
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000652
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.0149
Gnomad NFE exome
AF:
0.000572
Gnomad OTH exome
AF:
0.00293
GnomAD4 exome
AF:
0.000873
AC:
1276
AN:
1461858
Hom.:
8
Cov.:
33
AF XY:
0.000908
AC XY:
660
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00113
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.0154
Gnomad4 NFE exome
AF:
0.000311
Gnomad4 OTH exome
AF:
0.000977
GnomAD4 genome
AF:
0.00118
AC:
179
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.00176
AC XY:
131
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00135
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0133
Gnomad4 NFE
AF:
0.000441
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000530
Hom.:
1
Bravo
AF:
0.000147
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxSep 21, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Brugada syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 24, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 16, 2020This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
Cadd
Benign
13
Dann
Benign
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113645050; hg19: chr3-32181818; COSMIC: COSV56992282; API